Top compounds associated with response to MYO1F


Feature Type Standardized
Nominal ANOVA
mRNA TKI258 CCLE pan-cancer AAC 0.25 7e-07
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.26 8e-07
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.2 1e-06
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA BMS-536924 GDSC1000 pan-cancer AAC 0.18 2e-06
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.2 2e-06
mRNA AZD7762 GDSC1000 pan-cancer AAC 0.17 2e-06
mRNA AZ628 GDSC1000 pan-cancer AAC 0.25 2e-06
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-06
Download CSV